Clinical Development Strategy Consultant
Clinical development strategy that connects science, regulatory expectations, feasibility, capital requirements and enterprise value.
Gisselbaek Consulting helps companies translate data packages, assumptions and scientific rationale into credible clinical development plans. The work is especially relevant when a company needs to make a programme investable, decision-ready or partner-ready.
Support areas
- Clinical development strategy and indication prioritisation.
- Study concept, endpoint, patient population and comparator logic.
- Regulatory and payer-aligned evidence planning.
- Timeline, capital requirement and feasibility scenario analysis.
- Clinical risk architecture for investors, boards and executive teams.
Who this helps
- Biotech companies preparing for first clinical study or proof of concept.
- Medtech companies defining evidence generation strategy.
- Specialty pharma teams planning lifecycle or geographic expansion.
- Investors reviewing whether a clinical path is credible and value-creating.